Impaired Regulation by IL-35 in Systemic Sclerosis
This study investigated the role of IL-35 in systemic sclerosis (SSc) patients, focusing on CD4+ T cell response and immunomodulatory cytokine production. By comparing the cytokine levels in healthy donors (HD) and SSc patients using ELISAs, we found a significantly lower plasma IL-35 concentration...
Main Authors: | Rubén Osuna-Gómez, Ivan Castellví, Maria Mulet, Mª Àngels Ortiz, Douglas E. Brough, Helen Sabzevari, Roshanak T. Semnani, Silvia Vidal |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-06-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/24/13/10567 |
Similar Items
-
Estimating the salivary levels of IL-35 in smokers with periodontitis: A cross sectional study
by: P. Yuvashri, et al.
Published: (2024-01-01) -
Current Insight into the Role of IL-35 and Its Potential Involvement in the Pathogenesis and Therapy of Atopic Dermatitis
by: Weronika Zysk, et al.
Published: (2022-12-01) -
Correlation analysis between IL-35, IL-36γ, CCL27 and psoriasis vulgaris
by: Jiao Chen, et al.
Published: (2021-08-01) -
CD19+CD24highCD27+ B cell and interleukin 35 as potential biomarkers of disease activity in systemic lupus erythematosus patients
by: Hui Xiong, et al.
Published: (2022-12-01) -
Interleukin-35 in autoimmune dermatoses: Current concepts
by: Xie Yuming, et al.
Published: (2022-03-01)